28RO

split variant of Aquifex aeolicus lumazine synthase-derived nucleocapsid variant NC-4

これはPDB形式変換不可エントリーです。

28RO の概要

• エントリーDOI: 10.2210/pdb28ro/pdb
• EMDBエントリー: 56772
• 分子名称: 6,7-dimethyl-8-ribityllumazine synthase (2 entities in total)
• 機能のキーワード: capsid, design, virus mimic, virus like particle
• 由来する生物種: Aquifex aeolicus; 詳細
• タンパク質・核酸の鎖数: 480
• 化学式量合計: 5203570.08

構造登録者

Tetter, S.,Hilvert, D. (登録日: 2026-02-16, 公開日: 2026-04-29, 最終更新日: 2026-06-10)

主引用文献

Levasseur, M.D.,Terasaka, N.,Steinauer, A.,Tetter, S.,Pfister, S.,Meier, B.H.,Hilvert, D.
An engineered closed-shell, two-component, 480-subunit nucleocapsid.
Proc.Natl.Acad.Sci.USA, 123:e2530090123-e2530090123, 2026

PubMed Abstract: Self-assembling protein cages are valuable nanoscale containers for biotechnology and medical applications. Two-component systems are especially attractive due to their potential for functional complexity. In this study, we demonstrate that the subunits of the 240-subunit nucleocapsid NC-4, which was previously evolved to package and protect its encoding mRNA, can be split into two fragments without disrupting cage assembly or structure, generating a two-component, 480-subunit capsid. This modification introduces additional termini on the cage's exterior surface, creating opportunities for functionalization. We exploited these new sites by genetically appending peptide and protein tags to the exterior surface of split NC-4 (spNC-4), enabling site-specific glycosylation via posttranslational modification and cell-specific delivery by targeted antibody recruitment. Our findings broaden the utility of the NC-4 nucleocapsid. By extension, splitting related protein compartments that bind diverse cargoes could offer a robust platform for biotechnological applications requiring simultaneous encapsulation and customizable surface modification.

PubMed: 42201976
DOI: 10.1073/pnas.2530090123

実験手法

ELECTRON MICROSCOPY (3.1 Å)